Market Place
Sourcing Support
OMass Therapeutics Expands Team With Key Appointments In US, UK
01 Oct 2024 //
GLOBENEWSWIRE
OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024
05 Aug 2024 //
GLOBENEWSWIRE
OMass Expands Scientific Advisory Board with the Appointment of Sarah Teichmann
08 Apr 2024 //
GLOBENEWSWIRE
OMass expands leadership team with the appointment of Melissa Faris as CBO
15 Nov 2023 //
GLOBENEWSWIRE
OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board
26 Sep 2023 //
GLOBENEWSWIRE
OMass Therapeutics Expands Leadership Team with Two New Appointments
02 Aug 2023 //
GLOBENEWSWIRE
OMass Therapeutics Announces Appointment of New Board Chair & Series B Extension
15 May 2023 //
GLOBENEWSWIRE
OMass Therapeutics Announces New Phase of Growth with Move to New Facilities
19 Apr 2023 //
GLOBENEWSWIRE
Publication in Nature Chemistry Demonstrates the Benefits of Native Mass
10 Nov 2022 //
GLOBENEWSWIRE
OMass Therapeutics Raises $100 Million in Series B Financing
28 Apr 2022 //
GLOBENEWSWIRE
OMass Establishes Scientific Advisory Board of Leading Experts
07 Mar 2022 //
GLOBENEWSWIRE
OMass` OdyssION DD Platform Makes Progress in Drugging the Undruggable
28 Feb 2022 //
GLOBENEWSWIRE
OMass Therapeutics to Present at Upcoming Conferences
21 Feb 2022 //
GLOBENEWSWIRE
OMass Unveils Rich Drug Discovery Pipeline
03 Nov 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.